Sacubitril/valsartan decreases plasma NT-proBNP in HF patients with preserved ejection fraction: JAMA Medha3 Dec 2021 3:30 AM GMTGermany: Sacubitril/valsartan significantly decreased plasma NT-proBNP levels at 12 weeks compared with standard medical therapies in patients with...
Empagliflozin safe in acute HF, improves 'Clinical Benefit' over time Dr. Nandita Mohan2 Dec 2021 5:12 AM GMTPatients with acute heart failure were safely started on empagliflozin a median of 3 days after hospitalization and were 36% more likely to...
Medical Bulletin 30/November/2021 Dr. Nandita Mohan30 Nov 2021 11:55 AM GMTHere are Top Medical stories of the daySevere hypoglycemia related to heart failure risk in T2DSevere hypoglycemia is associated with a greater risk of...
Severe hypoglycemia related to heart failure risk in type 2 diabetes patients: Study Medha29 Nov 2021 4:45 AM GMTUSA: Severe hypoglycemia is associated with a greater risk of heart failure, reveals a study of a large cohort of adults with type 2 diabetes. The...
Sacubitril/Valsartan does not best valsartan in patients with advanced heart failure: LIFE Trial Medha24 Nov 2021 3:30 AM GMTThe trial found no significant improvements with the combination drug when compared with valsartan in terms of the primary endpoint.USA: Sacubitril/val...
Aspirin intake potentially linked to incident heart failure: ESC study Dr Kartikeya Kohli23 Nov 2021 6:07 AM GMTAspirin use is associated with a 26% raised risk of heart failure in people with at least one predisposing factor for the condition. Predisposing...
What ESC 2021 guidelines say about use of Mineralocorticoid Receptor Antagonist (MRA) in HFrEF? Dr. Prem Aggarwal18 Nov 2021 6:27 AM GMTThe European Society of Cardiology (ESC) has recently issued guidelines to include Mineralocorticoid Receptor Antagonist (MRA) besides ACE-I and...
MRA Strongly Recommended in Treatment of Heart Failure with Reduced Ejection Fraction: 2021 ESC Guidelines Medical Dialogues Bureau17 Nov 2021 7:15 AM GMTPharmacotherapy is the cornerstone of treatment for Heart Failure with Reduced Ejection Fraction (HFrEF) and should be implemented before considering...
Insulin use increases mortality risk in diabetic patients with heart failure: Study MD Editorial Team5 Nov 2021 5:15 AM GMTKorea: In a study conducted by Se Yong Jang and his team, it was found that insulin treatment is associated with greater mortality risk in heart...
Diabetes with cardiomyopathy tied to higher risk of heart failure: JACC Medha5 Nov 2021 5:15 AM GMTUSA: According to a recent study in the Journal of the American College of Cardiology (JACC), the prevalence of diabetes with cardiomyopathy (DbCM) amo...
One size fits all, not true for BP- Different BP targets for Heart and Brain: Study Dr Sravan Kumar28 Oct 2021 3:30 AM GMTExisting data from SPRINT Trial demonstrated favorable outcomes in terms of CV events and deaths by SBP target of <120 mm Hg as compared to target...
Heart failure prediction with SPECT scan yields good results Dr. Nandita Mohan27 Oct 2021 10:14 AM GMTCardiac 123I-MIBG SPECT imaging is beneficial in providing prognostic information in nonischemic ADHF patients with HFpEF, according to a study...
